Publications

[ 2025 ]

1. Tran, NL and Oh SJ* "Human opsin restoration by histone methylation using methyltransferase fusion protein SETD7-dCas9

", Molecular Therapy Nucleic Acids, Volume 36, 3, 102677 September 2025, (IF:6.1)    

2. Rajangam et al. "Human Dermal Fibroblast Spheroid Overexpressing Matrix Metalloproteinase-1 Serves as a 3D Platform for In Vitro Drug Screening", BioChip Journal, Volume 19, pages 324–339, March 2025

3. Heo EJ,  Kim Y, Chang JW, Youn UJ,  Oh SJ* and Lee S* "Ferroptosis-Mediated Anti-Cancer Activity of Endoperoxide-Containing Steroids Derived from Daedaleopsis confragosa via Targeting NOS2", Animal Cells and Systems (Accepted) 

[ 2024 ]

1.  Kim et al.  "TRPA1 nanovesicle-conjugated receptonics for rapid biocide screening", Journal of Hazardous Materials  Volume 477, 15 September 2024, 135282 (2024), (IF:12.2)

2.  Chung H, Choi J, Hong C, Lee Y, Hong KH, Oh SJ, Kim J, Song S and Kim S  “A micro-fragmented collagen gel as a cell-assembling platform for critical limb ischemia repair ” Bioactive Materials 34 (2024) 80-97, (IF:18.9) 

3.  Ahn B, Park K and Oh SJ*  "Exosomal miRNA-29c derived from M1 Macrophages Regulates a Cholesterol Metabolism via Regulation of ENPP2 Expression for Anti-Tumor Efficacy", Cancer Cell International (2024), 24, Article number: 325 (IF:5.8)

[ 2023 ]

1.  Kim H, Roh H, Kim S, Lee K, Im M and Oh SJ* “Effective Protection of Photoreceptors Using an Inflammation-Responsive Hydrogel via Attenuating Inflammatory Activities in Outer Retinal Degenerative Disease” npg Regenerative Medicine  8, Article number: 68 (2023), (IF:7.2) 

2. Kim H, Tran NL and Oh SJ* "AI-driven New Therapeutic Strategy Targeting STK33 for Cancer Treatment ", Cancer Cell International (2023), 23, Article number: 321 (IF:5.8)

3. Park B, Bang S, Hwang KS, Cha YK, Kwak J, Tran NL, Kim H, Park S, Oh SJ, Im M, Chung S, Kim J, Park TH, Song HS, Kim HN, Kim JH " Eye‐mimicked Neural Network Composed of Photosensitive Neural Spheroids with Human Opsin Proteins", Advanced Materials (2023) (IF=29.4)

4. Choi J, Chung H, Oh SJ, Kim J, Kim S " Functionally enhanced cell spheroids for stem cell therapy: Role of TIMP1 in the survival and therapeutic effectiveness of stem cell spheroids", Acta Biomaterialia (2023) (IF:9.7)

5. Hong C, Chung H, Lee G, Kim G, Kim D, Oh SJ, Kim S, Lee K "Hydrogel/Nanofiber Composite Wound Dressing Optimized for Skin Layer Regeneration through the Mechanotransduction-Based Microcellular Environme", ACS Applied Bio Materials  (2023)

[2022]

1.   Kim SM, Kim H Oh SJ* and Hwang S* “Soft, Wireless Electronic Dressing System for Wound Analysis and Biophysical Therapy” Nano Today (2022), 47, 101685 (*Co-corresponding) (IF=18.962)

2.   Tran LN, Lee IK, Kim H, Lee K, Kim S and Oh SJ* “Facile construction of tumour spheroids with induced M2 macrophage polarization for anticancer drug screening” Biomedical Materials (2022) 17, Number 6 (IF=4.103)

3.   Dos Santos Da Costa A, Subbiah R, Oh SJ, Jeong H, Na J, Park K, Choi I, Shin JH “ Fibroblasts Close a Void in Free Space by a Purse-String Mechanism” ACS Applied Materials and Interfaces (2022), 14, 36, 40522-40534 (IF=10.383)

4.   Shin C, Kim H, Kim S, Lee JY, Lee JM and Oh SJ* “Cytosolic microRNA-inducible nuclear translocation of Cas9 protein for disease-specific genome modification” Nucleic Acid Research (2022), 50, 10, 5919–5933 (IF=19.160)

5.  Kim H, Joo Y, Kook Y, Tran NL, Kim S, Lee K and Oh SJ* “On-demand Local Immunomodulation via Epigenetic Control of Macrophages using an Inflammation-responsive Hydrogel for Accelerated Wound Healing” ACS Applied Materials and Interfaces (2022), 14, 4, 4931–4945 (IF=10.383)

[2021]

1.   Bae IY, Choi W, Oh SJ, Kim C and Kim S “Engineered 3D Multicellular Breast Tumor Spheroid for Drug Screening: A tool for evaluating drug resistance in solid tumors” Bioengineering and Translational Medicine (2021), e10286 (IF=10.711)

2.   Choi J, Choi W, Oh SJ and Kim S "FGF2-primed 3D spheroids producing IL-8 promote therapeutic angiogenesis in murine hindlimb ischemia" (2021), npg Regenerative Medicine (2021), 6 (1), 1-15

(IF=10.364)

3.   Tran LN, Lee IK, Choi JK, Kim S and Oh SJ* " Acetate decreases PVR/CD155 expression via PI3K/ Akt pathway in cancer cells " (2021), BMB Reports 54(8): 431-436. (IF=4.778)

[2020]

1.  Shin C, Byun J, Lee K, Kim B, Noh YK, Tran NL, Park K, Kim S, Kim TH and Oh SJ* " Exosomal miRNA-19a and miRNA-614 induced by air pollutants promote pro-inflammatory M1 macrophage polarization via regulation of RORα expression in human respiratory mucosal microenvironment" J. Immunol. (2020) 205 (11), 3179-3190 (IF=5.422)

2.   Lee H, Kim TH, Park D, Jang M, Chung J, Kim SH, Kim S, Lee KH, Jung Y and Oh SJ* “Combinatorial Inhibition of Cell Surface Receptors using Dual Aptamer-functionalized Nanoconstructs for Cancer Treatment” Pharmaceutics (2020) 12(7), 689 (IF=6.321)

3.    Lee IK, Song H, Kim H, Kim IS, Tran LN, Oh SJ* and Lee JM " RORα Regulates Cholesterol Metabolism of CD8+ T Cell for Anti-Cancer Immunity" Cancers. (2020) 12 (7), 1733 (*Co-corresponding) (IF=6.639)

4.    Hong S, Oh SJ, Choi D, Hwang Y and Kim S “Self-organized Liver Microtissue on a Bio-functional Surface: The Role of Human Adipose-derived Stromal Cells in Hepatic Function” IJMS (2020) 21(13), 4605 (IF=5.923)

5.   Nam S, Pahk KJ, Jeon S, Park H, Kim GB, Oh SJ, Kim K, Kim H and Yang Y “Investigation of the Potential Immunological Effects of Boiling Histotripsy for Cancer Treatment” Advanced Therapeutics (2020) DOI: 10.1002/adtp.201900214 (IF=1.45)

6.   Lee J, Oh SJ, An SH, Kim WD and Kim S “Machine Learning-Based Design Strategy for 3D-printable Bioink: Elastic Modulus and Yield Stress Determine Printability” Biofabrication (2020) May 28;12(3):035018 (IF=9.954)

7.   Seok JM, Rajangam T, Jeong JE, Cheong S, Joo SM, Oh SJ, Shin H, Kim S and Park SA “Fabrication of 3D Plotted Scaffold With Microporous Strands for Bone Tissue Engineering” J Mater Chem B (2020) Feb 7;8(5):951-960 (IF=6.331)

[2019]

1.   Byun J, Song B, Kim B, Ok M, Lee K, Baek S, Kim S, Oh SJ* and Kim TH “Identification of disrupted human airway epithelium by urban particulate matter using respiratory mucosa-on-a-chip” Journal of Biological Engineering (*Co-corresponding) (2019) Nov 15;13:88 (IF=4.335)

2.   Pahk KJ, Shin C, Bae IY, Yang Y, Kim S, Pahk K, Kim H and Oh SJ* " High-intensity Focused Ultrasound-induced Mechanical Ablation (Boiling Histotripsy) modulates Tumor Microenvironment by promoting Immunogenic Cell Death of Cancers" Sci Rep. (2019) Jun 21;9(1):9050 (IF=4.379)

3.   Lee J, Song B, Subbiah R, Chung J, Choi U, Park K, Kim S and Oh SJ* "Effect of chain flexibility on cell adhesion: Semi-flexible model-based analysis of cell adhesion to hydrogels" Sci Rep. (2019) Feb 21;9(1):2463 (IF=4.379)

[2018]

1.   Suhaeri M, Noh MH, Moon J, Kim IG, Oh SJ, Ha SS, Lee JH, Park K. “Novel skin patch combining human fibroblast-derived matrix and ciprofloxacin for infected wound healing” Theranostics (2018) 8(18):5025-5038 (IF=11.556)

2.   Kim SM, Shin SC, Kim EK, Kim S, Park K, Oh SJ* and Jang M “Simple in vivo gene editing via direct self-assembly of Cas9 Ribonucleoprotein Complexes for Cancer Treatment” ACS Nano (*Co-corresponding) (2018) Aug 28;12(8):7750-7760 (IF=15.881)

3.   Park B, Yang H, Ha, TH, Park HS, Oh SJ, Ryu YS, Cho Y, Kim HS, Oh J, Lee DK, Kim C, Lee T, Seo M, Choi J, Jhon YM, Woo DH, Lee S, Kim SH, Lee HJ, Jun SC, Song HS, Park TH, Kim JH “Artificial Rod and Cone Photoreceptors with Human-Like Spectral Sensitivities” Advanced Materials (2018) Jul;30(27) (IF=30.849)

4.   Kang JM, Yoon JK, Oh SJ and Kim S “Synergistic Therapeutic Effect of Three-Dimensional Stem Cell Clusters and Angiopoietin-1 on Promoting Vascular Regeneration in Ischemic Region” Tissue Engineering Part A (2018) Apr;24(7-8):616-630 (IF=3.845)

[~ 2017]

1.   Kim SM, Yang Y, Hong Y, Oh SJ and Jang M “Cancer-derived nanovesicles as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting” (2017)  J Control Release 28;266:8-16 (IF=9.776)

2.   Du P, Suhaeri M, Ha SS, Oh SJ, S Kim and K Park “Human lung fibroblast-derived matrix facilitates vascular morphogenesis in 3D environment and enhances skin wound healing” (2017) Acta Biomater. Vol 54, 333-344 (IF=8.947)

3.   Suhaeri M, Subbiah R, Kim S, Kim C, Oh SJ, S Kim and K Park “Novel Platform of Cardiomyocyte Culture and Coculture via Fibroblast-Derived Matrix-Coupled Aligned Electrospun Nanofiber” (2017) ACS Appl Mater Interfaces 9, 224−235 (IF=9.229)

4.   Park J, Kim I, Han S, Park I, Kim C, Bae J, Oh SJ, Lee S, Kim JH, Woo D, He Y, Augustin HG, Kim I, Lee D and Koh GY “Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment.” (2016) Cancer Cell  Volume 30, Issue 6, p953–967, 12 (IF=31.743)

5.   Lee JM, Lee SH, Hwang JW, Oh SJ, Kim B, Jung S, Shim SH, Lin PW, Lee SB, Cho MY, Koh YJ, Kim SY, Ahn S, Lee J, Kim KM, Cheong KH, Choi J, Kim KA, “ Novel strategy for a bispecific antibody: induction of dual target internalization and degradation” (2016) Oncogene 2016 Feb 8 (IF=9.867)

6.   Han S, Lee SJ, Kim KE, Lee HS, Oh N, Park I, Ko E, Oh SJ, Lee YS, Kim D, Lee S, Lee DH, Lee KH, Chae SY, Lee JH, Kim SJ, Kim HC, Kim S, Kim SH, Kim C, Nakaoka Y, He Y, Augustin HG, Song PH, Kim YI, Kim P, Kim I, Koh GY “Amelioration of Sepsis by Tie2 Activation-Induced Vascular Protection” (2016) Sci Transl Med. 2016 Apr 20;8(335):335ra55 (IF=17.956)

7.   Monteleon CL, McNeal A, Duperret EK, Oh SJ, Schapira E, Ridky TW, “IQGAP1 and IQGAP3 Serve Individually Essential Roles in Normal Epidermal Homeostasis and Tumor Progression” (2015) J Invest Dermatol. 2015 Sep;135(9):2258-65 (IF=8.551)

8.   Lee HS*, Oh SJ*, Lee KH, Lee YS, Ko E, Kim KE, Kim HC, Kim S, Song PH, Kim YI, Kim C, Han S., “Gln-362 of angiopoietin-2 mediates migration of tumor and endothelial cells through association with α5β1 integrin” (2014) J Biol Chem. 2014 Nov 7;289(45):31330-40. (*Equal contribution) (IF=5.157)

9.   Oh YM, Lee SB, Choi J, Suh HY, Shim S, Song YJ, Kim B, Lee JM, Oh SJ, Jeong Y, Cheong KH, Song PH, Kim KA, “USP8 modulates ubiquitination of LRIG1 for Met degradation” (2014) Sci Rep. 2014 May 15;4:4980. (IF=4.379)

10.  Duperret EK, Oh SJ, McNeal A, Prouty SM, Ridky TW, “Activating FGFR3 mutations cause mild hyperplasia in human skin, but are insufficient to drive benign or malignant skin tumors” (2014) Cell Cycle. 2014;13 (10):1551-9 (IF=4.534)

11.  Oh SJ*and Santy LC, “Phosphoinositide Specificity Determines Which Cytohesins Regulates β1 Integrin Recycling” (2012) JCS 2012 Jul 1;125(Pt 13):3195-201 (IF=5.285)

12.  Oh SJ*and Santy LC, “Differential Effects of  cytohesin 2 and 3 on β1 Integrin Recycling ” (2010) JBC 285 (19) 14610-14616 (IF=5.157)

13.  Shim JK, Kim SW, Oh SJ, Ning K, Zatsiorsky VM and Latash ML, “Plastic changes in interhemispheric inhibition with practice of a two-hand force production task: a transcranial magnetic stimulation study” (2005) Neurosci Lett 10;374(2) 104-8 (IF=3.046)

[List of Patents, registered]

1.       Bi-functionalized nanoparticles and use thereof, KR102109932

2.       Fusion Protein for Crisp/Cas System and Complex Comprising the Same and Uses 

          Therefore, US16/156864/KR102067675

3.       Anti-ang2 antibody, US9828422B2/ EP2832746B1

4.       Method of blocking vascular leakage using an anti-ang2 antibody, US9902767B2 

           / EP2835380B1

5.       Biomarker PNCK for predicting effect of a dual-targeting agent, US 20160033518 A1

6.       Biomarker HSP90 for predicting effect of a c-Met inhibitor, US9956244B2

7.       Anti-c-Met/Anti-Ang2 Bispecific Antibody, US9808507B2

8.       Polypeptide, Anti-VEGF Antibody, and Anti-c-Met/Anti-VEGF Bispecific Antibodies  

          comprising the same, US 20160090427 A1

[List of Patents, applied]

1. PCT/KR2021/009223 (2021.07.19)

2. PCT/KR2021/008609 (2021.07.06)

3. PCT/KR2020/018577 (2020.12.17)

4. 2020-0093127 (2020.07.27)

5. PCT/KR2021/001569 (2021.07.06)

6. 16/898072 (2020.06.10)

7. 2020-0064617 (2020.05.28)

8.          Vegf-binding fragment mutant, and fusion protein comprising vegf-binding 

             fragment mutant and anti-c-met antibody, WO2017/200173 A1